Company / Current Liabilities per Share
Royalty Pharma plc Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.06
FY2025
5-year range
$0.39 / $3.11
FY2021-FY2025
Trend
-63.1%
vs FY2024
Sector context
#111 of 210
Health Care
What the data says
At $1.06, Royalty Pharma plc's current liabilities per share ranks #100 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 6 years, ranging from $0.39 in FY2023 to $3.11 in FY2022.
Based on SEC 10-K filings.
1.06 in FY2025 with a 5-year CAGR of +5.2%.
Increased from $0.39 to $1.06 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -30.2%
- 5-Year CAGR
- +5.2%
- 10-Year CAGR
- -
Sector benchmark
#100 of 210 in Health CareTop 47% of 210This company $1.06 Sector average $15.78
▼
-93.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 63.1% year-over-year.
- Ranks #111 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.06 | -63.1% |
| FY2024 | $2.86 | +635.7% |
| FY2023 | $0.39 | -87.5% |
| FY2022 | $3.11 | +581.3% |
| FY2021 | $0.46 | -44.4% |
| FY2020 | $0.82 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026